8 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Omeros Corporation | 7 |
| University of Leicester | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18523203 | ANTIBODIES SPECIFICALLY BINDING TO MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | Omeros Corporation | WEN, SHARON X | 1641 | Non-Final OA | Nov 29, 2023 |
| 18451632 | Methods and Compositions for Treating Cancer | Omeros Corporation | PAK, MICHAEL D | 1674 | Non-Final OA | Aug 17, 2023 |
| 18176155 | HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS | Omeros Corporation | KIM, YUNSOO | 1641 | Non-Final OA | Feb 28, 2023 |
| 18168192 | COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION | Omeros Corporation | SKELDING, ZACHARY S | 1644 | Non-Final OA | Feb 13, 2023 |
| 18152536 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | Omeros Corporation | SKELDING, ZACHARY S | 1644 | Non-Final OA | Jan 10, 2023 |
| 18051993 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | University of Leicester | BENAVIDES, JENNIFER ANN | 1675 | Non-Final OA | Nov 02, 2022 |
| 17823793 | TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | Omeros Corporation | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Non-Final OA | Aug 31, 2022 |
| 17665176 | BIOMARKER FOR ASSESSING THE RISK OF DEVELOPING ACUTE COVID-19 AND POST-ACUTE COVID-19 | Omeros Corporation | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | Feb 04, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial